L
LSL Pharma Group Inc
XTSX:LSL
LSL Pharma Group Inc
XTSX:LSL
Price:
0.435
CAD
Market Closed
Market Cap:
CA$55.1m
Balance Sheet
Balance Sheet Decomposition
LSL Pharma Group Inc
LSL Pharma Group Inc
Balance Sheet Decomposition is not available for
LSL Pharma Group Inc
LSL Pharma Group Inc
Balance Sheet
LSL Pharma Group Inc
LSL Pharma Group Inc
Currency: CAD
| Jul-2010 | Jul-2011 | Jul-2012 | Jul-2021 | Jul-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
3
|
5
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
4
|
9
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
0
|
7
|
15
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
15
|
23
|
|
| Intangible Assets |
0
|
0
|
1
|
0
|
0
|
9
|
13
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
+16%
|
1
+427%
|
0
-98%
|
0
+50%
|
31
+103 233%
|
54
+74%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
3
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
6
|
4
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
15
|
10
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
7
|
17
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Total Liabilities |
0
N/A
|
0
+300%
|
0
+100%
|
0
+150%
|
0
+45%
|
22
+7 486%
|
29
+32%
|
|
| Equity | ||||||||
| Common Stock |
0
|
0
|
3
|
3
|
3
|
24
|
36
|
|
| Retained Earnings |
0
|
0
|
2
|
4
|
4
|
18
|
15
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
2
|
3
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
N/A
|
1
+500%
|
0
N/A
|
0
-37%
|
9
N/A
|
25
+189%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
+16%
|
1
+427%
|
0
-98%
|
0
+50%
|
31
+103 233%
|
54
+74%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
0
|
0
|
1
|
1
|
1
|
82
|
116
|
|
Switch to:
Switch to:
See Also
Discover More
